Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer.

Duconge J, Miranda-Massari JR, González MJ, Taylor PR, Riordan HD, Riordan NH, Casciari JJ, Alliston K.

Ann Pharmacother. 2007 Jun;41(6):1082-3. Epub 2007 May 22. No abstract available.

PMID:
17519294
2.

A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.

Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA.

P R Health Sci J. 2005 Dec;24(4):269-76.

PMID:
16570523
3.

Intravenously administered vitamin C as cancer therapy: three cases.

Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M.

CMAJ. 2006 Mar 28;174(7):937-42.

4.

Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs.

Casciari JJ, Riordan HD, Miranda-Massari JR, Gonzalez MJ.

P R Health Sci J. 2005 Jun;24(2):145-50.

PMID:
16116933
5.

Orthomolecular oncology review: ascorbic acid and cancer 25 years later.

González MJ, Miranda-Massari JR, Mora EM, Guzmán A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Román-Franco A.

Integr Cancer Ther. 2005 Mar;4(1):32-44. Review.

PMID:
15695476
6.

Changes in USDA food composition data for 43 garden crops, 1950 to 1999.

Davis DR, Epp MD, Riordan HD.

J Am Coll Nutr. 2004 Dec;23(6):669-82.

PMID:
15637215
7.

Activation of Raf1 and the ERK pathway in response to l-ascorbic acid in acute myeloid leukemia cells.

Park S, Park CH, Hahm ER, Kim K, Kimler BF, Lee SJ, Park HK, Lee SH, Kim WS, Jung CW, Park K, Riordan HD, Lee JH.

Cell Signal. 2005 Jan;17(1):111-9.

PMID:
15451031
8.

Intravenous ascorbic acid as a treatment for severe jellyfish stings.

Kumar S, Miranda-Massari JR, Gonzalez MJ, Riordan HD.

P R Health Sci J. 2004 Jun;23(2):125-6.

PMID:
15377062
9.

Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.

Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.

P R Health Sci J. 2004 Jun;23(2):115-8.

PMID:
15377059
10.

Erythrocyte membrane fatty acid composition in cancer patients.

Mikirova N, Riordan HD, Jackson JA, Wong K, Miranda-Massari JR, Gonzalez MJ.

P R Health Sci J. 2004 Jun;23(2):107-13.

PMID:
15377058
11.

Cell membrane fatty acid composition differs between normal and malignant cell lines.

Meng X, Riordan NH, Riordan HD, Mikirova N, Jackson J, González MJ, Miranda-Massari JR, Mora E, Trinidad Castillo W.

P R Health Sci J. 2004 Jun;23(2):103-6.

PMID:
15377057
12.

L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60.

Han SS, Kim K, Hahm ER, Lee SJ, Surh YJ, Park HK, Kim WS, Jung CW, Lee MH, Park K, Yang JH, Yoon SS, Riordan NH, Riordan HD, Kimler BF, Park CH, Lee JH, Park S.

J Cell Biochem. 2004 Oct 1;93(2):257-70.

PMID:
15368354
13.

L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms.

Park S, Han SS, Park CH, Hahm ER, Lee SJ, Park HK, Lee SH, Kim WS, Jung CW, Park K, Riordan HD, Kimler BF, Kim K, Lee JH.

Int J Biochem Cell Biol. 2004 Nov;36(11):2180-95.

PMID:
15313465
14.

Vitamin C pharmacokinetics: implications for oral and intravenous use.

Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M.

Ann Intern Med. 2004 Apr 6;140(7):533-7.

PMID:
15068981
15.

Intravenous ascorbic acid: protocol for its application and use.

Riordan HD, Hunninghake RB, Riordan NH, Jackson JJ, Meng X, Taylor P, Casciari JJ, González MJ, Miranda-Massari JR, Mora EM, Rosario N, Rivera A.

P R Health Sci J. 2003 Sep;22(3):287-90.

PMID:
14619456
16.

Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis.

Meng XL, Riordan NH, Casciari JJ, Zhu Y, Zhong J, González MJ, Miranda-Massari JR, Riordan HD.

P R Health Sci J. 2002 Dec;21(4):323-8.

PMID:
12572240
17.

Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity.

González MJ, Miranda-Massari JR, Mora EM, Jiménez IZ, Matos MI, Riordan HD, Casciari JJ, Riordan NH, Rodríguez M, Guzmán A.

P R Health Sci J. 2002 Mar;21(1):39-41. Review.

PMID:
12013679
18.

Inhibition of human breast carcinoma cell proliferation by ascorbate and copper.

González MJ, Mora EM, Miranda-Massari JR, Matta J, Riordan HD, Riordan NH.

P R Health Sci J. 2002 Mar;21(1):21-3.

PMID:
12013676
19.

Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours.

Casciari JJ, Riordan NH, Schmidt TL, Meng XL, Jackson JA, Riordan HD.

Br J Cancer. 2001 Jun 1;84(11):1544-50.

20.

Integrative medicine: a paradigm shift in medical education and practice.

González MJ, Miranda-Massari JR, Mora EM, Cruzado NA, Jiménez I, Rosa M, Matos Vera MI, Santiago C, Román-Eyxarch MI, Rodríguez JR, Pérez Cortés C, Riordan NH, Riordan HD, Ricart CM.

P R Health Sci J. 2000 Dec;19(4):389-92.

PMID:
11293891
21.

Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent.

Riordan NH, Riordan HD, Meng X, Li Y, Jackson JA.

Med Hypotheses. 1995 Mar;44(3):207-13.

PMID:
7609676
22.

Improved microplate fluorometer counting of viable tumor and normal cells.

Riordan HD, Riordan NH, Meng X, Zhong J, Jackson JA.

Anticancer Res. 1994 May-Jun;14(3A):927-31.

PMID:
8074495
23.

Comparison of two cytotoxic food sensitivity tests.

Jackson JA, Riordan HD, Neathery S.

Am Clin Lab. 1991 Mar;10(2):20-1. No abstract available.

PMID:
10148230
24.

Aluminium from a coffee pot.

Jackson JA, Riordan HD, Poling CM.

Lancet. 1989 Apr 8;1(8641):781-2. No abstract available.

PMID:
2564585
25.

Differences in human serum copper and zinc levels in healthy and patient populations.

Cheraskin E, Carpenter JH, Riordan HD.

Med Hypotheses. 1986 May;20(1):79-85.

PMID:
3636582
26.

Clinical correlations between serum glucose variance and reported symptoms in human subjects.

Riordan HD, Hinshaw CT Jr, Carpenter J, Landreth M, Cheraskin E.

Med Hypotheses. 1984 Sep;15(1):67-79.

PMID:
6387406

Supplemental Content

Loading ...
Support Center